Manage the risk of nitrosamines in the pharmaceutical industry. Watch our webinar on demand and learn about regulation and risk analysis from experts.
Nitrosamine impurities have become a critical and ongoing challenge for the pharmaceutical industry. Regulatory expectations continue to evolve, acceptable exposure limits(AELs)are being reassessed based on evolving toxicological evidence.
In this webinar, our experts will explain why nitrosamines should remain a priority for pharmaceutical organizations and how the regulatory framework is shaping current and future compliance requirements.
You will gain clear insight into the data and inputs needed to perform an effective nitrosamine risk assessment (NRA). We will also explore the critical factors that influence nitrosamine formation and how to interpret assessment outcomes to define appropriate actions.
The session concludes with practical case studies and mitigation strategies, helping you translate regulatory and toxicological concepts into actionable steps for risk minimization.
向最优秀的人学习
Our speakers bring hands-on experience from toxicology, regulatory compliance, and pharmaceutical development. They will translate complex scientific and regulatory requirements into practical guidance that you can apply in your daily work.
Toxicology Consultant
Pabloholds a degree in Chemistry and a Master’s degree in Organic Chemistry from the Autonomous University of Madrid (UAM). He currently works as a Toxicology Consultant at QbD Group, with a strong focus on nitrosamine-related regulatory requirements. With over five years of experience in organic synthesis and drug development, he has worked in multiple research laboratories and developed hands-on expertise in a wide range of analytical techniques.
Global Toxicology Liaison
She holds a PhD in Pharmacy from the University of Medical Sciences of Costa Rica and a Master’s degree in Drug Research, Development and Innovation from the University of Navarra. With a strong background in business development, she previously worked at a preclinical CRO, where she played a key role in driving growth and establishing strategic partnerships. Her professional experience also includes roles as a Medical Sales Representative at several companies, including Abbott. In addition, she has gained valuable experience in quality assurance through her work at Pfizer and other pharmaceutical manufacturing sites, ensuring compliance with industry standards.
Is this for you?
Learn from our experts
Quality Assurance(QA) and Quality Control (QC) professionals are responsible for ensuring product compliance
Regulatory Affairs(RA) professionals involved in regulatory strategy, submissions, and interactions with regulatory authorities
CMC, manufacturing, and technical operations teams supporting nitrosamine risk assessments and mitigation strategies
Technology Transfer professionals involved in process and product knowledge transfer across development and manufacturing stages
Formulation and Pharmaceutical Development (R&D) teams involved in product and process design with potential impact on nitrosamine risk
Keep watching
点播网络研讨会This webinar provides guidance on managing pharmacovigilance (PV) across Europe, focusing on balancing global consistency with country-specific requirements. Participants will learn to meet strict European timelines while working with lean teams and practical strategies to enhance oversight and execution.
立即观看
点播网络研讨会This webinar offers a foundational understanding of Extractables and Leachables (E&L), highlighting their impact on drug safety and stability, and current regulatory frameworks. It covers toxicological assessments and best practices in study design, supported by real-world examples to navigate the complex landscape surrounding E&L.
立即观看
点播网络研讨会This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
立即观看专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
